JAVIER
SASTRE VALERA
Profesor asociado de Ciencias de la Salud
Instituto Valenciano de Oncologia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (10)
2018
-
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer
International Journal of Cancer, Vol. 143, Núm. 8, pp. 1954-1962
2012
-
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A spanish cooperative group for the treatment of digestive tumors study
Oncologist, Vol. 17, Núm. 7, pp. 947-955
-
First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103
-
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Oncologist, Vol. 17, Núm. 1, pp. 15-25
-
Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study
PLoS ONE, Vol. 7, Núm. 10
2010
-
Practical prognostic index for patients with metastatic recurrent breast cancer: Retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
Breast Cancer Research and Treatment, Vol. 122, Núm. 2, pp. 591-600
2003
-
Irinotecan (CPT-11) in Metastatic Colorectal Cancer Patients Resistant to 5-Fluorouracil (5-FU): A Phase II Study
Methods and Findings in Experimental and Clinical Pharmacology, Vol. 25, Núm. 8, pp. 639-643
2001
-
Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trial
Clinical colorectal cancer, Vol. 1, Núm. 1, pp. 43-46
2000
-
Two consecutive studies using oral UFT-based chemotherapy regimens in elderly patients with advanced colorectal cancer
Clinical and Translational Oncology, Vol. 2, Núm. 3, pp. 154-158
1999
-
UFT Plus or Minus Calcium Folinate for Metastatic Golorectal Cancer in Older Patients
ONCOLOGY, Vol. 13, Núm. 7 SUPPL., pp. 35-40